Monte Rosa Therapeutics, Inc. (GLUE) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading GLUE…

Monte Rosa Therapeutics, Inc. (GLUE) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

Monte Rosa Therapeutics, Inc.

GLUE · CIK 1826457

4 · Oct 6, 2026 · Principal Accounting Officer Bowen Matthew sold 13 shares at $10.56/share ($137)

4

Principal Accounting Officer Bowen Matthew sold 13 shares at $10.56/share ($137)

Filed: Oct 6, 2026
Period: Oct 5, 2026
Accession: 0001193125-26-415540
Filer: Monte Rosa Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov